1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,405 | 0,478 | 06.12. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.11. | Lifecare ASA: Financial calendar | 1 | Oslo Børs | ||
| 05.11. | Lifecare ASA: Lifecare shares key learnings from ongoing longevity study LFC-SEN-002 | 2 | Oslo Børs | ||
| 22.10. | LIFECARE ASA: Extraordinary General Meeting | 3 | Oslo Børs | ||
| 22.10. | Lifecare ASA: Key information relating to the proposed partially underwritten rights issue | 4 | Oslo Børs | ||
| 22.10. | Lifecare ASA: Proposed partially underwritten rights issue | 2 | Oslo Børs | ||
| 26.09. | Lifecare ASA: Mandatory notification of trade | - | Oslo Børs | ||
| LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
| 24.09. | Lifecare ASA: Lifecare strengthens miniaturisation roadmap with new patent applications | 1 | Oslo Børs | ||
| 15.09. | Lifecare ASA: LIFECARE RESUBMITS APPLICATION FOR FIRST-IN-HUMAN CLINICAL STUDY | 1 | Oslo Børs | ||
| 27.08. | Lifecare ASA: Reconfirmed positive results in veterinary study support path toward market entry | 3 | Oslo Børs | ||
| 20.08. | LIFE: Lifecare ASA Q2 2025 results | 4 | Oslo Børs | ||
| 13.08. | Lifecare ASA: Lifecare advances CE mark preparation for its groundbreaking medical device | 4 | Oslo Børs | ||
| 12.08. | Lifecare ASA: Invitation to presentation of Q2 2025 results 20 August at 10.45 CEST | 3 | Oslo Børs | ||
| 05.08. | Lifecare ASA Secures REK Ethics Approval For First-In-Human CGM Trial | 2 | RTTNews | ||
| 05.08. | Lifecare ASA: Lifecare receives ethics approval to initiate first-in-human trial in Norway | 3 | Oslo Børs | ||
| 08.07. | Lifecare ASA: Lifecare achieves full radio frequency compliance for CGM implant clearing the way for CE mark of electronics | 2 | Oslo Børs | ||
| 01.07. | Lifecare ASA: Lifecare advances electromagnetic compatibility compliance testing for CGM implant | 1 | Oslo Børs | ||
| 25.06. | Lifecare ASA: Share capital increase registered | 2 | Oslo Børs | ||
| 13.06. | Lifecare ASA: Final results following expiry of the exercise period for the Warrants issued in connection with the Rights Issue | 2 | Oslo Børs | ||
| 13.06. | Lifecare ASA: Notification of trade - exercise of warrants | - | Oslo Børs | ||
| 13.06. | Lifecare ASA: Last day of the Exercise Period for the Warrants issued in connection with the Rights Issue | 1 | Oslo Børs |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 85,72 | -0,29 % | NextTrip, Inc.: NextTrip's JOURNY Expands Global Reach with Launch on Apple iOS, Roku, and Android | New Apps Deepen Audience Engagement and Extend JOURNY's Rebrand Momentum Across Major Platforms SANTA FE, NEW MEXICO / ACCESS Newswire / December 4, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip,"... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,080 | -7,02 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 83,60 | -0,24 % | Boston Scientific Corporation (BSX): A Bull Case Theory | ||
| PAUL HARTMANN | 218,00 | +0,46 % | Januar bis September 2025: PAUL HARTMANN steigert Umsatz trotz schwächerer Absatzmärkte | Heidenheim (ots) - - Umsatzerlöse steigen auf 1.826,0 Mio. EUR, organisches Umsatzwachstum von 2,0 % - Bereinigtes EBITDA liegt bei 195,8 Mio. EUR, bereinigte EBITDA-Rendite bei 10,7 % - Unternehmen... ► Artikel lesen | |
| SYSMEX | 8,150 | -0,61 % | Sysmex H1 Profit Declines | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Sysmex Corporation reported that its first half profit attributable to owners of the
parent was 19.0 billion yen, a decline of 26.9% from prior year. Earnings... ► Artikel lesen | |
| ADDLIFE | 16,570 | +1,35 % | AddLife AB: AddLife acquires Opitek International ApS | AddLife has acquired Opitek International ApS ("Opitek"), a manufacturer specializing in patient positioning. The company will become part of Mediplast, a company within AddLife's Business Area Medtech.AddLife... ► Artikel lesen | |
| EMBECTA | 9,750 | -3,47 % | Dividendenbekanntmachungen (05.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUSHNET HOLDINGS CORP US0050981085 0,235 USD 0,2017 EUR AGRICULTURAL BANK OF CHINA LTD CNE100000Q43 0,1195 CNY 0,0144 EUR AMERISAFE... ► Artikel lesen | |
| ENOVIS | 24,200 | +4,31 % | Enovis Corporation: Enovis Announces Third Quarter 2025 Results | Diversified growth platform delivers third-quarter sales growth of 9% on a reported basis, 7% organically Third-quarter Reconstructive sales grew 12% year-over-year on a reported basis, 9% organically... ► Artikel lesen | |
| KANGJI MEDICAL | 1,033 | -100,00 % | KANGJI MEDICAL (09997): JOINT ANNOUNCEMENT - (1) PROPOSAL FOR THE PRIVATISATION OF KANGJI MEDICAL HOLDINGS LIMITED BY THE OFFEROR BY WAY OF A SCHEME OF ... | ||
| PULMONX | 1,780 | +13,38 % | Pulmonx Corporation: Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ||
| SI-BONE | 16,600 | -1,78 % | SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance | Delivered ~21% worldwide revenue growth, ~5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter 2025 Financial Highlights (all comparisons are to the... ► Artikel lesen | |
| PEIJIA MEDICAL | 0,605 | +0,83 % | PEIJIA-B (09996): VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD | ||
| KOOTH | 1,380 | +0,73 % | Kooth übernimmt US-Plattform für Kinder-Teletherapie | ||
| BACTIGUARD | 1,275 | -2,30 % | Bactiguard Holding AB: Bactiguard Holding AB's interim report third quarter 2025 | Continued profitability and clinical evidence supporting future growth
Third quarter 2025 (July - September)
Total revenue amounted to SEK 48.4 (73.9) million, a decrease of SEK 25.5 million corresponding... ► Artikel lesen | |
| SCIBASE | 0,006 | +24,00 % | SciBase publishes information document regarding the offer to repurchase outstanding warrants of series TO 2 | STOCKHOLM, Dec. 5, 2025 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") publishes an information document in connection with the offer to repurchase all outstanding... ► Artikel lesen |
LIFECARE ASA gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,421 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.